EP0382526A2 — Substituted -1,3-oxathiolanes with antiviral properties
Assigned to Shire Canada Inc · Expires 1990-08-16 · 36y expired
What this patent protects
Disclosed are compounds of the formula wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agen…
USPTO Abstract
Disclosed are compounds of the formula wherein R₁ is hydrogen; R₂ is a purine or pyrimidine base or an analogue or derivative thereof; Z is S, S=O or SO₂; and pharmaceutically acceptable derivatives thereof. Also described are use of the compounds as antiviral agents, pharmaceutical formulations, and methods for the preparation of the compounds.
Drugs covered by this patent
- Sustiva (EFAVIRENZ) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.